Health X Platform hosts investor meet at GIA Healthcare Day

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Health X Platform Limited will host an investor meet on August 31, 2026
  • The event is part of the GIA Healthcare Day in Mumbai
  • Only public domain information will be shared during the session
  • The meeting runs from 2:00 pm to 3:30 pm at Jio World Convention Centre
powered bylight_fuzz_icon
49191906

*this image is generated using AI for illustrative purposes only.

Health X Platform Limited will host representatives of investors and analysts at the GIA Healthcare Day. The group conference is scheduled for Monday, August 31, 2026, from 2:00 pm to 3:30 pm at the Jio World Convention Centre in Mumbai.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company, formerly known as Sastasundar Ventures Limited, confirmed that the interaction will be conducted as a group conference.

Meeting Details

The event is part of the broader GIA Healthcare Day schedule. Interested parties can register through the link provided in the official exchange filing. The company noted that the schedule remains subject to change due to exigencies on the part of the analysts or investors.

Event Name GIA Healthcare Day
Meeting Type Group Conference
Venue Jio World Convention Centre, Mumbai
Timings Monday, August 31, 2026, from 2:00 pm to 3:30 pm

Information Disclosure Policy

Health X Platform Limited emphasized that only information available in the public domain will be shared or discussed during the interaction. The company explicitly stated that no unpublished price-sensitive information will be disclosed to participants. This approach aligns with standard regulatory compliance for such investor engagements.

Historical Stock Returns for Health X Platform

1 Day5 Days1 Month6 Months1 Year5 Years
+2.21%-0.78%-4.31%+5.93%+9.91%+4.75%

How might the strategic rebranding from Sastasundar Ventures to Health X Platform influence investor sentiment and valuation multiples during the GIA Healthcare Day?

What specific growth metrics or expansion plans in the healthcare sector is Health X likely to highlight to differentiate itself from peers at this group conference?

Could the timing of this investor engagement signal upcoming regulatory filings or strategic partnerships that are not yet public?

Health X Platform Q1 Results: Revenue rises 58% YoY to ₹440 crore

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Health X Platform reported Q1 FY27 revenue of ₹440 crore, up 58% YoY. Net profit reached ₹2 crore, reversing a prior quarter loss, aided by treasury income. Gross margin improved to 7.8%, while EBITDA loss narrowed to ₹15 crore as the company expands geographically and invests in technology.

powered bylight_fuzz_icon
48524848

*this image is generated using AI for illustrative purposes only.

Health X Platform delivered its strongest quarterly performance to date in Q1 FY27, driven by robust growth across its B2B and B2C segments. Revenue from operations rose 58% year-on-year to ₹440 crore, marking a sequential improvement of over 16% from ₹378 crore in Q4 FY26. The company returned to profitability, reporting a net profit of ₹2 crore, a significant turnaround from the net loss of ₹13 crore recorded in the preceding quarter.

Financial Performance

The top-line momentum was supported by an expansion in gross profit, which grew 64% year-on-year to ₹34 crore. Gross margin improved sequentially to 7.8% from 7.3% in Q4 FY26. Operating efficiency also showed signs of stabilization, with EBITDA loss narrowing to ₹15 crore from ₹20 crore in the prior quarter, translating to an EBITDA margin improvement to negative 3.4% from negative 5.5%. Despite these gains, management noted that higher employee and other operating expenses continued to impact EBITDA levels.

Metric: Q1 FY27 Q4 FY26 Change
Revenue: ₹440 crore ₹378 crore +16% QoQ
Gross Profit: ₹34 crore ₹27.4 crore* +24% QoQ
EBITDA: -₹15 crore -₹20 crore Narrowed
Net Profit: ₹2 crore -₹13 crore Turnaround

*Derived from disclosed growth rates and current figures.

Segment Growth and Strategy

Growth was broad-based across the company’s core platforms. The B2B segment, RetailerShakti, expanded 48% year-on-year, while the B2C platform, SastaSundar, grew 44% year-on-year. Management highlighted that 69.4% of RetailerShakti orders exceeded ₹2,500, indicating deeper wallet share among retailers. Similarly, 69.2% of SastaSundar orders were above ₹1,000, reflecting healthy consumer basket sizes.

Geographical expansion remains a key strategic pillar. While West Bengal continues to contribute approximately 30% of revenue, the company has accelerated penetration into Odisha, Bihar, Jharkhand, and Chhattisgarh. Northern operations have been strengthened through new infrastructure in Noida, with further expansion into Haryana, Uttar Pradesh, and Rajasthan. Management noted that tier-2 and tier-3 markets now account for 67% of RetailerShakti business and 78% of SastaSundar business.

What the Numbers Show

A critical observation from the quarter is the divergence between operational losses and net profitability. While EBITDA remained negative at ₹15 crore due to heavy investments in technology and expansion, the company reported a net profit of ₹2 crore. This discrepancy is largely attributable to significant other income, primarily treasury income from capital reserves built after the sale of the SastaSundar business to Flipkart. This structure suggests that current net profitability is not yet driven by core operations but rather by financial assets, highlighting that the underlying business model is still in an investment phase with high burn rates directed toward technology and geographic scaling.

Outlook and Investments

Management indicated that July 2026 revenue crossed ₹150 crore, suggesting sustained momentum into Q2. The company is focusing on launching RetailAir, an AI-monitored SaaS product for retailers, expected in the next quarter. Additionally, the private label initiative, JITO, saw revenue rise from ₹25 lakh in Q4 FY26 to ₹79 lakh in Q1 FY27, with gross margins exceeding 50%. Fulfillment infrastructure is being scaled with new warehouses in Noida, Guwahati, Lucknow, and Udaipur to support projected growth, with existing capacity sufficient to handle up to ₹3,000 crore in annual revenue.

Historical Stock Returns for Health X Platform

1 Day5 Days1 Month6 Months1 Year5 Years
+2.21%-0.78%-4.31%+5.93%+9.91%+4.75%

How sustainable is the current net profitability given that it is driven by treasury income rather than core operational EBITDA?

What specific monetization strategies will RetailAir employ to convert its AI capabilities into recurring SaaS revenue for retailers?

Can the high gross margins of the JITO private label initiative be scaled nationally without compromising quality or supply chain efficiency?

More News on Health X Platform

1 Year Returns:+9.91%